Here are the Form 4 insider transactions from Centene Corporation (CNC) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow CNC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CNC filings page.
Centene Corporation’s Chief Financial Officer, Asher Andrew Lynn, reported an equity award of 173,573 shares of common stock on January 26, 2026, at a price of $0 per share. This grant brings his directly held beneficial ownership of Centene common stock to 831,215.48 shares.
The award includes 69,429 restricted stock units that vest in three annual installments beginning March 15, 2027, and 104,144 performance stock units reported at target, which may vest on March 15, 2029 from 0% to 200% of target based on stock price performance tests. He also holds 13,449 performance stock options with a $81.85 exercise price expiring December 15, 2031, which become exercisable only if Centene’s stock trades at or above $100 for 20 consecutive trading days after the December 15, 2021 grant date.
Centene Corp’s Chief People Officer, Tanya M. McNally, reported a routine tax-related share transaction. On 01/15/2026, 725 shares of Centene common stock were withheld at a price of $46.17 per share to cover taxes due on the vesting of a previously reported grant of restricted stock units. After this withholding, she beneficially owns 58,769 shares of Centene common stock, which includes 49,340 shares in the form of previously granted restricted stock units and performance stock units reported at target performance and still subject to vesting requirements.
Centene Corporation director reports a routine stock grant. On 12/31/2025, the reporting person acquired 790 shares of Centene common stock at a price of $0, indicating an award rather than an open-market purchase.
After this grant, the director beneficially owned 6,738 shares of Centene common stock in direct ownership. The filing also explains that this total includes 3,579 shares of restricted stock units that are subject to vesting requirements, meaning some shares will only be fully owned if those conditions are met.
Centene Corp director updates equity ownership in a routine insider filing. On 12/31/2025, the director acquired 608 shares of Centene common stock at a reported price of $0, likely reflecting a grant rather than an open-market purchase. Following this transaction, the director beneficially owns 19,812.979 shares directly, including 3,579 restricted stock units that are subject to vesting requirements, and 32,000 shares held indirectly through a revocable family trust where he serves as co‑trustee.
The filing also lists a stock option giving the right to buy 10,000 shares of Centene common stock at an exercise price of $80.57, exercisable from 02/07/2025 until 02/07/2032, with all 10,000 derivative securities currently reported as beneficially owned.
Centene Corp director Christopher A. Koster reported acquiring 608 shares of Centene common stock on 12/31/2025 at a price of $0 per share. Following this transaction, he beneficially owned 360,360.658 shares of Centene common stock in total. The filing notes that this ownership includes 5,965 shares of restricted stock units that are subject to vesting requirements. The securities are held in direct ownership form.
Centene Corporation director Robert K. Coughlin reported updated holdings of the company’s stock and options. On 12/31/2025, he acquired 729 shares of common stock at a stated price of $0, bringing his directly held common stock to 13,016.926 shares.
He also reports 30,054 shares held indirectly through a grantor retained annuity trust. His ownership includes 3,579 restricted stock units that are subject to vesting. In addition, he holds a stock option to buy 10,000 Centene common shares at an exercise price of $80.57, exercisable from 02/07/2025 until expiration on 02/07/2032.
Centene Corporation director Robert K. Burdick reported a small increase in his ownership of company stock. On 12/31/2025, he acquired 729 shares of common stock at $0, which typically reflects a vested equity award rather than an open-market purchase. After this transaction, he directly holds 273,093.924 shares of Centene common stock.
Burdick also reports 86,498 shares held indirectly through Burdick Family LLC, where he is a chief manager and disclaims beneficial ownership except for his economic interest. His reported ownership includes 3,579 restricted stock units that are still subject to vesting. In addition, he holds a stock option to buy 10,000 shares at $80.57 per share, exercisable starting 02/07/2025 and expiring on 02/07/2032.
Centene Corp director reports stock sales and remaining holdings. A Centene Corp (CNC) director sold 33,211 shares of common stock on 12/03/2025 at a weighted average price of $39.04 per share, and 32,796 shares on 12/04/2025 at $39.00 per share. After these transactions, the director directly beneficially owned 305,160.924 shares of Centene common stock, which include 3,579 restricted stock units that are subject to vesting requirements. In addition, the director had indirect beneficial ownership of 86,498 shares held by Burdick Family LLC, for which he is a chief manager and disclaims beneficial ownership except for his pecuniary interest. The filing also notes stock options covering 10,000 shares of common stock at an exercise price of $80.57, exercisable from 02/07/2025 until 02/07/2032.